drugset / Trial / NCT00125047

Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood

NCT00125047

RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study is part of the International Vaccine Institute's (IVI's) typhoid Vi demonstration project that aims to accelerate the rational introduction of Vi vaccines in typhoid endemic countries. The purpose of this study is to determine the effectiveness of the Vi vaccine following a mass typhoid immunization campaign in an endemic area in Karachi, Pakistan. The cost-effectiveness of Vi vaccination and the logistic feasibility of a mass typhoid immunization campaign will also be evaluated.

Timeline

Start
2001-10
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Havrix Vaccine 720 unknown
Subject Typhoid Vi vaccine Vaccine 25 ug